Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
33.17
+0.07 (0.21%)
At close: Jun 15, 2026, 4:00 PM EDT
33.33
+0.16 (0.48%)
After-hours: Jun 15, 2026, 6:35 PM EDT
Cogent Biosciences Market Cap
Cogent Biosciences has a market cap or net worth of $5.67 billion as of June 15, 2026. Its market cap has increased by 814.70% in one year.
Market Cap
5.67B
Enterprise Value
5.07B
1-Year Change
814.70%
Ranking
Category
Stock Price
$33.17
Market Cap Chart
Since July 10, 2020, Cogent Biosciences's market cap has increased from $124.27M to $5.67B, an increase of 4,461.93%. That is a compound annual growth rate of 90.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 15, 2026 | 5.67B | 4.91% |
| Dec 31, 2025 | 5.40B | 527.16% |
| Dec 31, 2024 | 861.60M | 70.14% |
| Dec 29, 2023 | 506.41M | -37.32% |
| Dec 30, 2022 | 807.97M | 136.30% |
| Dec 31, 2021 | 341.92M | -2.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PTC Therapeutics | 6.23B |
| Centessa Pharmaceuticals | 6.15B |
| Mirum Pharmaceuticals | 6.06B |
| Rhythm Pharmaceuticals | 6.06B |
| Belite Bio | 5.44B |
| Scholar Rock Holding | 5.29B |
| CG Oncology | 5.25B |
| Ligand Pharmaceuticals | 5.12B |